Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)

Free Medical Books

  Prostate Cancer

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    March 2012
  1. BOONSIRIKAMCHAI P , Kaur H, Kuban DA, Jackson E, et al
    Use of maximum slope images generated from dynamic contrast-enhanced MRI to detect locally recurrent prostate carcinoma after prostatectomy: a practical approach.
    AJR Am J Roentgenol. 2012;198:W228-36.
    PubMed     Text format     Related articles    Abstract available



  2. MORGAN VA , Riches SF, Giles S, Dearnaley D, et al
    Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy.
    AJR Am J Roentgenol. 2012;198:596-602.
    PubMed     Text format     Related articles    Abstract available



    February 2012
  3. CYRAN CC , Paprottka PM, Schwarz B, Sourbron S, et al
    Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study.
    AJR Am J Roentgenol. 2012;198:384-91.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  4. OTO A , Yang C, Kayhan A, Tretiakova M, et al
    Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis.
    AJR Am J Roentgenol. 2011;197:1382-90.
    PubMed     Text format     Related articles    Abstract available



  5. MUGLIA VF , Westphalen AC, Wang ZJ, Kurhanewicz J, et al
    Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease.
    AJR Am J Roentgenol. 2011;197:1369-74.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  6. SUNG YS , Kwon HJ, Park BW, Cho G, et al
    Prostate Cancer Detection on Dynamic Contrast-Enhanced MRI: Computer-Aided Diagnosis Versus Single Perfusion Parameter Maps.
    AJR Am J Roentgenol. 2011;197:1122-9.
    PubMed     Text format     Related articles    Abstract available



  7. PARK BK , Park JW, Park SY, Kim CK, et al
    Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.
    AJR Am J Roentgenol. 2011;197:W876-81.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  8. LOW RN , Fuller DB, Muradyan N
    Dynamic Gadolinium-Enhanced Perfusion MRI of Prostate Cancer: Assessment of Response to Hypofractionated Robotic Stereotactic Body Radiation Therapy.
    AJR Am J Roentgenol. 2011;197:907-915.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  9. TAMADA T , Sone T, Higashi H, Jo Y, et al
    Prostate Cancer Detection in Patients With Total Serum Prostate-Specific Antigen Levels of 4-10 ng/mL: Diagnostic Efficacy of Diffusion-Weighted Imaging, Dynamic Contrast-Enhanced MRI, and T2-Weighted Imaging.
    AJR Am J Roentgenol. 2011;197:664-70.
    PubMed     Text format     Related articles    Abstract available



  10. HOWARD S , O'Regan K, Jagannathan J, Krajewski K, et al
    Extrapulmonary small cell carcinoma: a pictorial review.
    AJR Am J Roentgenol. 2011;197:W392-8.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  11. TAMADA T , Sone T, Jo Y, Hiratsuka J, et al
    Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and t2-weighted imaging in localizing tumors.
    AJR Am J Roentgenol. 2011;197:408-14.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  12. ROSENKRANTZ AB , Scionti SM, Mendrinos S, Taneja SS, et al
    Role of MRI in minimally invasive focal ablative therapy for prostate cancer.
    AJR Am J Roentgenol. 2011;197:W90-6.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  13. MURPHY RC , Kawashima A, Peller PJ
    The Utility of 11C-Choline PET/CT for Imaging Prostate Cancer: A Pictorial Guide.
    AJR Am J Roentgenol. 2011;196:1390-8.
    PubMed     Text format     Related articles    Abstract available



  14. TABATABAEI S , Saylor PJ, Coen J, Dahl DM, et al
    Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know.
    AJR Am J Roentgenol. 2011;196:1263-6.
    PubMed     Text format     Related articles    Abstract available



  15. VILANOVA JC , Barcelo-Vidal C, Comet J, Boada M, et al
    Usefulness of Prebiopsy Multifunctional and Morphologic MRI Combined With Free-to-Total Prostate-Specific Antigen Ratio in the Detection of Prostate Cancer.
    AJR Am J Roentgenol. 2011;196:W715-22.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  16. GILES SL , Morgan VA, Riches SF, Thomas K, et al
    Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components.
    AJR Am J Roentgenol. 2011;196:586-91.
    PubMed     Text format     Related articles    Abstract available



  17. VERMA S , Rajesh A
    A clinically relevant approach to imaging prostate cancer: self-assessment module.
    AJR Am J Roentgenol. 2011;196.
    PubMed     Text format     Related articles    Abstract available



  18. VERMA S , Rajesh A
    A clinically relevant approach to imaging prostate cancer: review.
    AJR Am J Roentgenol. 2011;196.
    PubMed     Text format     Related articles   



    February 2011
  19. VERMA S , Rajesh A, Morales H, Lemen L, et al
    Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    AJR Am J Roentgenol. 2011;196:374-81.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  20. ROSENKRANTZ AB , Kong X, Niver BE, Berkman DS, et al
    Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    AJR Am J Roentgenol. 2011;196:123-9.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  21. KIM CK , Park BK, Kim B
    Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
    AJR Am J Roentgenol. 2010;194:1461-9.
    PubMed     Text format     Related articles    Abstract available



  22. DE VISSCHERE PJ , De Meerleer GO, Futterer JJ, Villeirs GM, et al
    Role of MRI in follow-up after focal therapy for prostate carcinoma.
    AJR Am J Roentgenol. 2010;194:1427-33.
    PubMed     Text format     Related articles    Abstract available



  23. VERMA S , Rajesh A, Futterer JJ, Turkbey B, et al
    Prostate MRI and 3D MR Spectroscopy: How We Do It.
    AJR Am J Roentgenol. 2010;194:1414-26.
    PubMed     Text format     Related articles    Abstract available



  24. SONG I , Kim CK, Park BK, Park W, et al
    Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
    AJR Am J Roentgenol. 2010;194:W477-82.
    PubMed     Text format     Related articles    Abstract available



  25. TSUTSUMI M , Miyagawa T, Matsumura T, Endo T, et al
    Real-time balloon inflation elastography for prostate cancer detection and initial evaluation of clinicopathologic analysis.
    AJR Am J Roentgenol. 2010;194:W471-6.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  26. WOODFIELD CA , Tung GA, Grand DJ, Pezzullo JA, et al
    Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    AJR Am J Roentgenol. 2010;194:W316-22.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  27. FRANIEL T , Ludemann L, Rudolph B, Lutterbeck E, et al
    Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation.
    AJR Am J Roentgenol. 2010;194:675-81.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  28. ROSENKRANTZ AB , Neil J, Kong X, Melamed J, et al
    Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection.
    AJR Am J Roentgenol. 2010;194:446-52.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  29. KIM CK , Park BK, Kim B
    High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    AJR Am J Roentgenol. 2010;194:W33-7.
    PubMed     Text format     Related articles    Abstract available



    December 2009
  30. RICHES SF , Payne GS, Morgan VA, Sandhu S, et al
    MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
    AJR Am J Roentgenol. 2009;193:1583-91.
    PubMed     Text format     Related articles    Abstract available



    November 2009
  31. TRUIJERS M , Futterer JJ, Takahashi S, Heesakkers RA, et al
    In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent.
    AJR Am J Roentgenol. 2009;193:W437-41.
    PubMed     Text format     Related articles    Abstract available



    September 2009
  32. WESTPHALEN AC , Coakley FV, Kurhanewicz J, Reed G, et al
    Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features.
    AJR Am J Roentgenol. 2009;193:W238-43.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: